Switching to Sulphonylureas in Children With iDEND Syndrome Caused by KCNJ11 Mutations Results in Improved Cerebellar Perfusion

Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with theKCNJ11/S225T, del226-232 mutation

(2012) Domenica Battaglia et al.   PEDIATRIC DIABETES

Muscle Dysfunction Caused by a KATP Channel Mutation in Neonatal Diabetes Is Neuronal in Origin

(2010) R. H. Clark et al.   SCIENCE

EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2

(2009) Özlem L. Kapucu et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation

(2008) A. S. Slingerland et al.   DIABETIC MEDICINE

A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications

(2008) P. Tammaro et al.   DIABETOLOGIA

The G53D Mutation in Kir6.2 (KCNJ11) Is Associated with Neonatal Diabetes and Motor Dysfunction in Adulthood that Is Improved with Sulfonylurea Therapy

(2007) Joseph C. Koster et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM